Skip to main content

Fibulins and Their Role in the ECM

  • Chapter
  • First Online:
Tumor-Associated Fibroblasts and their Matrix

Part of the book series: The Tumor Microenvironment ((TTME,volume 4))

  • 1784 Accesses

Abstract

The fibulins are a group of glycoproteins that function predominantly though not exclusively in the extracellular matrix (ECM). In common with the fibrillins and hemicentins, which are also ECM protein families, their basic characteristic is an FC (fibulin-type) unit at the protein C-terminal preceded by an array of adjoining cbEGF (Ca++ binding epidermal growth factor-like) modules of varying number. They may have up to four protein domains (N, I, II, III) and can be subdivided into two main subgroups (1 and 2) (Timpl et al., Nat Rev Mol Cell Biol 4(6):479–489, 2003). Subgroup 1, which contains fibulin-1 and fibulin-2, has the largest molecules (Table 9.1). Fibulin-1 can have up to three protein domains but fibulin-2 is unique in also containing a large N domain preceding domain I at the N terminus of the protein. Subgroup 2 contains fibulin-3, fibulin-4 and fibulin-5 and these have three domains, one of which is very small. These complete molecules are much smaller than either of those in subgroup 1. The new fibulins, fibulin-6 and fibulin-7 are only being characterized presently.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Albig AR, Schiemann WP (2004) Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells. DNA Cell Biol 23(6):367–379

    Article  PubMed  CAS  Google Scholar 

  • Argraves WS, Dickerson K et al (1989) Fibulin, a novel protein that interacts with the fibronectin receptor beta subunit cytoplasmic domain. Cell 58(4):623–629

    Article  PubMed  CAS  Google Scholar 

  • Chaudhry SS, Gazzard J et al (2001) Mutation of the gene encoding fibrillin-2 results in syndactyly in mice. Hum Mol Genet 10(8):835–843

    Article  PubMed  CAS  Google Scholar 

  • Chu ML, Tsuda T (2004) Fibulins in development and heritable disease. Birth Defects Res C Embryo Today 72(1):25–36

    Article  PubMed  CAS  Google Scholar 

  • Cohen S, Elliott GA (1989) The stimulation of epidermal keratinization by a protein isolated from the submaxillary gland of the mouse. 1962. J Invest Dermatol 92(Suppl 4):157S; discussion 158S–159S

    Article  Google Scholar 

  • Dameron KM, Volpert OV et al (1994) The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin. Cold Spring Harb Symp Quant Biol 59:483–489

    Article  PubMed  CAS  Google Scholar 

  • de Vega S, Iwamoto T et al (2007) TM14 is a new member of the fibulin family (fibulin-7) that interacts with extracellular matrix molecules and is active for cell binding. J Biol Chem 282(42):30878–88

    Article  PubMed  CAS  Google Scholar 

  • de Vega S, Iwamoto T et al (2009) Fibulins: multiple roles in matrix structures and tissue functions. Cell Mol Life Sci 66(11–12):1890–1902

    Article  PubMed  CAS  Google Scholar 

  • Downing AK, Knott V et al (1996) Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders. Cell 85(4):597–605

    Article  PubMed  CAS  Google Scholar 

  • Gallagher WM, Argentini M et al (1999) MBP1: a novel mutant p53-specific protein partner with oncogenic properties. Oncogene 18(24):3608–3616

    Article  PubMed  CAS  Google Scholar 

  • Gallagher WM, Greene LM et al (2001) Human fibulin-4: analysis of its biosynthetic processing and mRNA expression in normal and tumour tissues. FEBS Lett 489(1):59–66

    Article  PubMed  CAS  Google Scholar 

  • Gallagher WM, Currid CA et al (2005) Fibulins and cancer: friend or foe? Trends Mol Med 11(7):336–340

    Article  PubMed  CAS  Google Scholar 

  • Giltay R, Timpl R et al (1999) Sequence, recombinant expression and tissue localization of two novel extracellular matrix proteins, fibulin-3 and fibulin-4. Matrix Biol 18(5):469–480

    Article  PubMed  CAS  Google Scholar 

  • Greene LM, Twal WO et al (2003) Elevated expression and altered processing of fibulin-1 protein in human breast cancer. Br J Cancer 88(6):871–878

    Article  PubMed  CAS  Google Scholar 

  • Hu Q, Loeys BL et al (2006) Fibulin-5 mutations: mechanisms of impaired elastic fiber formation in recessive cutis laxa. Hum Mol Genet 15(23):3379–3386

    Article  PubMed  CAS  Google Scholar 

  • Huber R, Scholze H et al (1980) Crystal structure analysis and molecular model of human C3a anaphylatoxin. Hoppe Seylers Z Physiol Chem 361(9):1389–1399

    Article  PubMed  CAS  Google Scholar 

  • Hubmacher D, El-Hallous EI et al (2008) Biogenesis of extracellular microfibrils: multimerization of the fibrillin-1 C terminus into bead-like structures enables self-assembly. Proc Natl Acad Sci U S A 105(18):6548–6553

    Article  PubMed  CAS  Google Scholar 

  • Hucthagowder V, Sausgruber N et al (2006) Fibulin-4: a novel gene for an autosomal recessive cutis laxa syndrome. Am J Hum Genet 78(6):1075–1080

    Article  PubMed  CAS  Google Scholar 

  • Hugli TE et al (1986) Biochemistry and biology of anaphylatoxins. Complement 3(3):111–127

    PubMed  CAS  Google Scholar 

  • Kieser A, Weich HA et al (1994) Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9(3):963–969

    PubMed  CAS  Google Scholar 

  • Kobayashi N, Kostka G et al (2007) A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization. J Biol Chem 282(16):11805–11816

    Article  PubMed  CAS  Google Scholar 

  • Loeys B, Van Maldergem L et al (2002) Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. Hum Mol Genet 11(18):2113–2118

    Article  PubMed  CAS  Google Scholar 

  • Marmorstein LY, Munier FL et al (2002) Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration. Proc Natl Acad Sci U S A 99(20):13067–13072

    Article  PubMed  CAS  Google Scholar 

  • Moll F, Katsaros D et al (2002) Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells. Oncogene 21(7):1097–1107

    Article  PubMed  CAS  Google Scholar 

  • Mukhopadhyay D, Tsiokas L et al (1995) Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 55(24):6161–6165

    PubMed  CAS  Google Scholar 

  • Pan TC, Kluge M et al (1993) Sequence of extracellular mouse protein BM-90/fibulin and its calcium-dependent binding to other basement-membrane ligands. Eur J Biochem 215(3):733–740

    Article  PubMed  CAS  Google Scholar 

  • Qing J, Maher VM et al (1997) Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines. Oncogene 15(18):2159–2168

    Article  PubMed  CAS  Google Scholar 

  • Reinhardt DP, Sasaki T et al (1996) Fibrillin-1 and fibulin-2 interact and are colocalized in some tissues. J Biol Chem 271(32):19489–19496

    Article  PubMed  CAS  Google Scholar 

  • Roger P, Pujol P et al (1998) Increased immunostaining of fibulin-1, an estrogen-regulated protein in the stroma of human ovarian epithelial tumors. Am J Pathol 153(5):1579–1588

    Article  PubMed  CAS  Google Scholar 

  • Sasaki T, Mann K et al (1997) Dimer model for the microfibrillar protein fibulin-2 and identification of the connecting disulfide bridge. EMBO J 16(11):3035–3043

    Article  PubMed  CAS  Google Scholar 

  • Savage CR Jr, Inagami T et al (1972) The primary structure of epidermal growth factor. J Biol Chem 247(23):7612–7621

    PubMed  CAS  Google Scholar 

  • Schiemann WP, Blobe GC et al (2002) Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion. Fibulin-5 is induced by transforming growth factor-beta and affects protein kinase cascades. J Biol Chem 277(30):27367–27377

    Article  PubMed  CAS  Google Scholar 

  • Schultz DW, Klein ML et al (2003) Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Hum Mol Genet 12(24):3315–3323

    Article  PubMed  CAS  Google Scholar 

  • Sisto M, D’Amore M et al (2009) Fibulin-6 expression and anoikis in human salivary gland epithelial cells: implications in Sjogren’s syndrome. Int Immunol 21(3):303–311

    Article  PubMed  CAS  Google Scholar 

  • Spencer JA, Hacker SL et al (2005) Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration. Proc Natl Acad Sci U S A 102(8):2946–2951

    Article  PubMed  CAS  Google Scholar 

  • Stone EM, Lotery AJ et al (1999) A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet 22(2):199–202

    Article  PubMed  CAS  Google Scholar 

  • Tarttelin EE, Gregory-Evans CY et al (2001) Molecular genetic heterogeneity in autosomal dominant drusen. J Med Genet 38(6):381–384

    Article  PubMed  CAS  Google Scholar 

  • Timpl R, Sasaki T et al (2003) Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol 4(6):479–489

    Article  PubMed  CAS  Google Scholar 

  • Twal WO, Czirok A et al (2001) Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. J Cell Sci 114(Pt 24):4587–4598

    PubMed  CAS  Google Scholar 

  • Wlazlinski A, Engers R et al (2007) Downregulation of several fibulin genes in prostate cancer. Prostate 67(16):1770–1780

    Article  PubMed  CAS  Google Scholar 

  • Wu YS, Bevilacqua VL et al (1995) Fibrillin domain folding and calcium binding: significance to Marfan syndrome. Chem Biol 2(2):91–97

    Article  PubMed  CAS  Google Scholar 

  • Xie L, Palmsten K et al (2008) Basement membrane derived fibulin-1 and fibulin-5 function as angiogenesis inhibitors and suppress tumor growth. Exp Biol Med (Maywood) 233(2):155–162

    Article  CAS  Google Scholar 

  • Xu X, Dong C et al (2007) Hemicentins assemble on diverse epithelia in the mouse. J Histochem Cytochem 55(2):119–126

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Helen C. M. Cooney .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Cooney, H.C., Gallagher, W.M. (2011). Fibulins and Their Role in the ECM. In: Mueller, M., Fusenig, N. (eds) Tumor-Associated Fibroblasts and their Matrix. The Tumor Microenvironment, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0659-0_9

Download citation

Publish with us

Policies and ethics